Jove
Visualize
Contact Us

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

457
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
457
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

297
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
297
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

276
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
276
Survival Curves01:18

Survival Curves

330
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
330
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

199
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
199
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  2. Systematically Identification Of Survival-associated Eqtls In A Japanese Kidney Cancer Cohort.
  1. Home
  2. Systematically Identification Of Survival-associated Eqtls In A Japanese Kidney Cancer Cohort.

Related Experiment Video

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

7.6K

Systematically identification of survival-associated eQTLs in a Japanese kidney cancer cohort.

Xiya Song1, Han Jin1, Xiangyu Li1

  • 1Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden.

Plos Genetics
|July 7, 2025

View abstract on PubMed

Summary
This summary is machine-generated.

Expression quantitative trait loci (eQTLs) offer prognostic insights in clear cell renal carcinoma (ccRCC). This study identified novel eQTLs linked to ccRCC survival, with cross-ethnic validation highlighting potential biomarkers.

More Related Videos

Quantitative Real-Time PCR Evaluation of microRNA Expressions in Mouse Kidney with Unilateral Ureteral Obstruction
07:36

Quantitative Real-Time PCR Evaluation of microRNA Expressions in Mouse Kidney with Unilateral Ureteral Obstruction

Published on: August 27, 2020

6.3K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

534

Related Experiment Videos

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

7.6K
Quantitative Real-Time PCR Evaluation of microRNA Expressions in Mouse Kidney with Unilateral Ureteral Obstruction
07:36

Quantitative Real-Time PCR Evaluation of microRNA Expressions in Mouse Kidney with Unilateral Ureteral Obstruction

Published on: August 27, 2020

6.3K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

534

Area of Science:

  • Genomics and Bioinformatics
  • Oncology
  • Molecular Biology

Background:

  • Clear cell renal carcinoma (ccRCC) is the most common kidney cancer subtype.
  • The prognostic significance of expression quantitative trait loci (eQTLs) in ccRCC is not well understood, especially in Asian populations.

Purpose of the Study:

  • To identify eQTLs in Japanese ccRCC patients.
  • To assess the association of eQTLs with patient survival.
  • To validate findings in an independent ccRCC cohort.

Main Methods:

  • Whole-exome and RNA sequencing data from 100 Japanese ccRCC patients.
  • Identification of eGenes and cis-eQTLs.
  • Survival analysis using multiple Cox proportional hazard models.
  • Validation in the Cancer Genome Atlas (TCGA) ccRCC cohort.

Main Results:

  • Identified 805 eGenes and 4,558 cis-eQTLs in the Japanese cohort.
  • Nine eGenes were significantly associated with overall survival (FDR < 0.05).
  • Exploratory analysis revealed 223 eQTLs regulating 54 eGenes with consistent prognostic effects.
  • Eight eQTLs regulating 11 eGenes showed reproducible survival associations across ethnicities, including variants in ERV3-1 and ANKRD20A7P.

Conclusions:

  • eQTLs play a significant role in ccRCC prognosis.
  • Identified specific eQTLs and eGenes with consistent prognostic value across different populations.
  • Variants in ERV3-1 and ANKRD20A7P show potential as cross-ethnic prognostic biomarkers for ccRCC.